CD44 Variant 9 Expression in Primary Early Gastric Cancer as a Predictive Marker for Recurrence

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2013.314
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Expression of Stemness Genes in Primary Breast Cancer Tissues: The Role of SOX2 as a Prognostic Marker for Detection of Early Recurrence

Oncotarget
Oncology
2014English

RIPK3 Expression as a Potential Predictive and Prognostic Marker in Metastatic Colon Cancer

Clinical and Investigative Medicine
Medicine
2019English

Metastasis-Associated Protein Is a Predictive Biomarker for Metastasis and Recurrence in Gastric Cancer

Oncology Reports
MedicineCancer ResearchOncology
2016English

Predictive Factors for Local Recurrence and Incomplete Resection of Early Gastric Cancer Treated by Endoscopic Resection: A Western Experience

Canadian Journal of Gastroenterology
2009English

Integrated Analysis Highlights APC11 Protein Expression as a Likely New Independent Predictive Marker for Colorectal Cancer

Scientific Reports
Multidisciplinary
2018English

Nomogram for Predicting Gastric Cancer Recurrence Using Biomarker Gene Expression

European Journal of Surgical Oncology
MedicineOncologySurgery
2020English

Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon Cancer

Clinical Cancer Research
Cancer ResearchOncology
2016English

An Early Male Breast Cancer Developed 9 Years After Operation for a Gastric Cancer

The journal of the Japanese Practical Surgeon Society
1992English

Elevated CD133, but Not VEGF or EGFR, as a Predictive Marker of Distant Recurrence After Preoperative Chemoradiotherapy in Rectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy